MYO15B

Across TCGA pan-cancer cohorts, MYO15B mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MYO15B’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MYO15B mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types MYO15B is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.

HNSC and COAD are the cancer types where MYO15B tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MYO15B mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	−0.921	.002	8	view →
COAD	All	All	−0.147	.018	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MYO15B–HNSC

Open the HNSC breakdown →